Petach-Tikva, Israel

Jacob Wolfman

This inventor holds 1 USPTO granted patent. Top assignees: Bar-Ilan University, Eybna Technologies Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacob Wolfman. Retrieved from https://idiyas.com/inventor/jacob-wolfman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jacob Wolfman: Innovator in THC Derivatives

Introduction

Jacob Wolfman is a notable inventor based in Petach-Tikva, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of THC derivatives. His work focuses on oral dosage forms that can be used for treating various diseases and disorders.

Latest Patents

Jacob Wolfman holds 1 patent for his innovative work on THC derivatives. His patent, titled "THC derivatives, oral dosage forms comprising same, uses thereof for treating diseases and disorders and synthesis thereof," provides formulations and synthesis methods for THC derivatives intended for oral administration. This invention aims to enhance the treatment options available for various medical conditions.

Career Highlights

Throughout his career, Jacob has worked with reputable institutions, including Bar-Ilan University and Eybna Technologies Ltd. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Jacob has collaborated with notable colleagues such as Amnon Albeck and Nadav Eyal. These partnerships have played a crucial role in the development of his innovative ideas and patents.

Conclusion

Jacob Wolfman is a pioneering inventor whose work in THC derivatives has the potential to impact the medical field significantly. His contributions reflect a commitment to advancing pharmaceutical science and improving treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…